Eidos Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
09.25.2018Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry
08.23.2018Eidos Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
08.07.2018BridgeBio Pharma launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
06.13.2018
page of14